Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities-Reference-Cited by-同舟云学术

Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities

Published:2016-05-24 Issue:11 Volume:59 Page:5488-5504
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Yong¹²,Wang Xiaoyan¹,Xiang Wei¹,He Lin¹,Tang Minghai¹,Wang Fang¹,Wang Taijin¹,Yang Zhuang¹,Yi Yuyao³,Wang Hairong¹,Niu Ting³,Zheng Li¹,Lei Lei¹,Li Xiaobin¹,Song Hang²,Chen Lijuan¹

Affiliation:

1. State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, 610041, China

2. School of Chemical Engineering, Sichuan University, Chengdu, 610065, China

3. Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, 610041, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00579

Reference44 articles.